 | • レポートコード：QYR9ST00614 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の肥満治療神経調節システム市場について調査・分析し、以下の構成でお届け致します。肥満治療神経調節システムの種類別には、迷走神経刺激装置、内臓神経刺激装置、深部脳刺激装置、脊髄刺激装置、自律神経刺激装置、その他に、用途別には、病院、診療所、外来手術センターに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別肥満治療神経調節システム売上データ ・地域別肥満治療神経調節システム市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別肥満治療神経調節システム市場規模：迷走神経刺激装置、内臓神経刺激装置、深部脳刺激装置、脊髄刺激装置、自律神経刺激装置、その他 ・用途別肥満治療神経調節システム市場規模：病院、診療所、外来手術センター ・主要メーカーの企業情報：Medtronic、Cyberonics、St. Jude Medical、BioControl Medical、Leptos Medical、EnteroMedics、Nevro、Nuvectra ・肥満治療神経調節システムの市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Neuromodulation has shown some benefit in treatment of obesity and it is less invasive than the gastric banding and gastric bypass, which are surgical treatment option for obesity. Obesity treating neuromodulation system works by manipulation the appetite signal between gut and the brain.North America region dominates the global obesity treating neuromodulation system market and is expected to continue to dominate the market over the forecast period. High adoption of neuromodulation system and increased regulatory approval of these devices in the region is expected to be factor for the growth of obesity treating neuromodulation system market. Europe is the second biggest market for the obesity treating neuromodulation system. Increasing prevalence of obesity and presence of market players is also driving the market of obesity treating neuromodulation system market in North America and Europe.
The global Obesity Treating Neuromodulation System market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Obesity Treating Neuromodulation System market based on company, product type, end user and key regions.
This report studies the global market size of Obesity Treating Neuromodulation System in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Obesity Treating Neuromodulation System in these regions.
This research report categorizes the global Obesity Treating Neuromodulation System market by top players/brands, region, type and end user. This report also studies the global Obesity Treating Neuromodulation System market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Medtronic
Cyberonics
St. Jude Medical
BioControl Medical
Leptos Medical
EnteroMedics
Nevro
Nuvectra
Market size by Product
Vagus Nerve Stimulator
Splanchnic Nerve Stimulator
Deep Brain Stimulator
Spinal Cord Stimulator
Autonomous Nerve Stimulator
Others
Market size by End User
Hospitals
Clinics
Ambulatory Surgical Centers
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Obesity Treating Neuromodulation System market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Obesity Treating Neuromodulation System market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Obesity Treating Neuromodulation System companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Obesity Treating Neuromodulation System submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Obesity Treating Neuromodulation System are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Obesity Treating Neuromodulation System market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Obesity Treating Neuromodulation System Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Obesity Treating Neuromodulation System Market Size Growth Rate by Product
1.4.2 Vagus Nerve Stimulator
1.4.3 Splanchnic Nerve Stimulator
1.4.4 Deep Brain Stimulator
1.4.5 Spinal Cord Stimulator
1.4.6 Autonomous Nerve Stimulator
1.4.7 Others
1.5 Market by End User
1.5.1 Global Obesity Treating Neuromodulation System Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Obesity Treating Neuromodulation System Market Size
2.1.1 Global Obesity Treating Neuromodulation System Revenue 2014-2025
2.1.2 Global Obesity Treating Neuromodulation System Sales 2014-2025
2.2 Obesity Treating Neuromodulation System Growth Rate by Regions
2.2.1 Global Obesity Treating Neuromodulation System Sales by Regions
2.2.2 Global Obesity Treating Neuromodulation System Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Obesity Treating Neuromodulation System Sales by Manufacturers
3.1.1 Obesity Treating Neuromodulation System Sales by Manufacturers
3.1.2 Obesity Treating Neuromodulation System Sales Market Share by Manufacturers
3.1.3 Global Obesity Treating Neuromodulation System Market Concentration Ratio (CR5 and HHI)
3.2 Obesity Treating Neuromodulation System Revenue by Manufacturers
3.2.1 Obesity Treating Neuromodulation System Revenue by Manufacturers (2014-2019)
3.2.2 Obesity Treating Neuromodulation System Revenue Share by Manufacturers (2014-2019)
3.3 Obesity Treating Neuromodulation System Price by Manufacturers
3.4 Obesity Treating Neuromodulation System Manufacturing Base Distribution, Product Types
3.4.1 Obesity Treating Neuromodulation System Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Obesity Treating Neuromodulation System Product Type
3.4.3 Date of International Manufacturers Enter into Obesity Treating Neuromodulation System Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Obesity Treating Neuromodulation System Sales by Product
4.2 Global Obesity Treating Neuromodulation System Revenue by Product
4.3 Obesity Treating Neuromodulation System Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Obesity Treating Neuromodulation System Breakdown Data by End User
6 North America
6.1 North America Obesity Treating Neuromodulation System by Countries
6.1.1 North America Obesity Treating Neuromodulation System Sales by Countries
6.1.2 North America Obesity Treating Neuromodulation System Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Obesity Treating Neuromodulation System by Product
6.3 North America Obesity Treating Neuromodulation System by End User
7 Europe
7.1 Europe Obesity Treating Neuromodulation System by Countries
7.1.1 Europe Obesity Treating Neuromodulation System Sales by Countries
7.1.2 Europe Obesity Treating Neuromodulation System Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Obesity Treating Neuromodulation System by Product
7.3 Europe Obesity Treating Neuromodulation System by End User
8 Asia Pacific
8.1 Asia Pacific Obesity Treating Neuromodulation System by Countries
8.1.1 Asia Pacific Obesity Treating Neuromodulation System Sales by Countries
8.1.2 Asia Pacific Obesity Treating Neuromodulation System Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Obesity Treating Neuromodulation System by Product
8.3 Asia Pacific Obesity Treating Neuromodulation System by End User
9 Central & South America
9.1 Central & South America Obesity Treating Neuromodulation System by Countries
9.1.1 Central & South America Obesity Treating Neuromodulation System Sales by Countries
9.1.2 Central & South America Obesity Treating Neuromodulation System Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Obesity Treating Neuromodulation System by Product
9.3 Central & South America Obesity Treating Neuromodulation System by End User
10 Middle East and Africa
10.1 Middle East and Africa Obesity Treating Neuromodulation System by Countries
10.1.1 Middle East and Africa Obesity Treating Neuromodulation System Sales by Countries
10.1.2 Middle East and Africa Obesity Treating Neuromodulation System Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Obesity Treating Neuromodulation System by Product
10.3 Middle East and Africa Obesity Treating Neuromodulation System by End User
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Company Business Overview
11.1.3 Medtronic Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Medtronic Obesity Treating Neuromodulation System Products Offered
11.1.5 Medtronic Recent Development
11.2 Cyberonics
11.2.1 Cyberonics Company Details
11.2.2 Company Business Overview
11.2.3 Cyberonics Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Cyberonics Obesity Treating Neuromodulation System Products Offered
11.2.5 Cyberonics Recent Development
11.3 St. Jude Medical
11.3.1 St. Jude Medical Company Details
11.3.2 Company Business Overview
11.3.3 St. Jude Medical Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.3.4 St. Jude Medical Obesity Treating Neuromodulation System Products Offered
11.3.5 St. Jude Medical Recent Development
11.4 BioControl Medical
11.4.1 BioControl Medical Company Details
11.4.2 Company Business Overview
11.4.3 BioControl Medical Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.4.4 BioControl Medical Obesity Treating Neuromodulation System Products Offered
11.4.5 BioControl Medical Recent Development
11.5 Leptos Medical
11.5.1 Leptos Medical Company Details
11.5.2 Company Business Overview
11.5.3 Leptos Medical Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Leptos Medical Obesity Treating Neuromodulation System Products Offered
11.5.5 Leptos Medical Recent Development
11.6 EnteroMedics
11.6.1 EnteroMedics Company Details
11.6.2 Company Business Overview
11.6.3 EnteroMedics Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.6.4 EnteroMedics Obesity Treating Neuromodulation System Products Offered
11.6.5 EnteroMedics Recent Development
11.7 Nevro
11.7.1 Nevro Company Details
11.7.2 Company Business Overview
11.7.3 Nevro Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Nevro Obesity Treating Neuromodulation System Products Offered
11.7.5 Nevro Recent Development
11.8 Nuvectra
11.8.1 Nuvectra Company Details
11.8.2 Company Business Overview
11.8.3 Nuvectra Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Nuvectra Obesity Treating Neuromodulation System Products Offered
11.8.5 Nuvectra Recent Development
12 Future Forecast
12.1 Obesity Treating Neuromodulation System Market Forecast by Regions
12.1.1 Global Obesity Treating Neuromodulation System Sales Forecast by Regions 2019-2025
12.1.2 Global Obesity Treating Neuromodulation System Revenue Forecast by Regions 2019-2025
12.2 Obesity Treating Neuromodulation System Market Forecast by Product
12.2.1 Global Obesity Treating Neuromodulation System Sales Forecast by Product 2019-2025
12.2.2 Global Obesity Treating Neuromodulation System Revenue Forecast by Product 2019-2025
12.3 Obesity Treating Neuromodulation System Market Forecast by End User
12.4 North America Obesity Treating Neuromodulation System Forecast
12.5 Europe Obesity Treating Neuromodulation System Forecast
12.6 Asia Pacific Obesity Treating Neuromodulation System Forecast
12.7 Central & South America Obesity Treating Neuromodulation System Forecast
12.8 Middle East and Africa Obesity Treating Neuromodulation System Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Obesity Treating Neuromodulation System Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Obesity Treating Neuromodulation System Product Picture
Table Obesity Treating Neuromodulation System Market Segments
Table Key Manufacturers Obesity Treating Neuromodulation System Covered
Table Global Obesity Treating Neuromodulation System Market Size Growth Rate by Product 2019-2025 (Units) & (Million US$)
Figure Global Obesity Treating Neuromodulation System Sales Market Share by Product 2014-2025
Figure Vagus Nerve Stimulator Product Picture
Table Major Manufacturers of Vagus Nerve Stimulator
Figure Splanchnic Nerve Stimulator Product Picture
Table Major Manufacturers of Splanchnic Nerve Stimulator
Figure Deep Brain Stimulator Product Picture
Table Major Manufacturers of Deep Brain Stimulator
Figure Spinal Cord Stimulator Product Picture
Table Major Manufacturers of Spinal Cord Stimulator
Figure Autonomous Nerve Stimulator Product Picture
Table Major Manufacturers of Autonomous Nerve Stimulator
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Obesity Treating Neuromodulation System Market Size Growth Rate by End User 2019-2025 (Units)
Figure Hospitals
Figure Clinics
Figure Ambulatory Surgical Centers
Figure Obesity Treating Neuromodulation System Report Years Considered
Figure Global Obesity Treating Neuromodulation System Market Size 2014-2025 (Million US$)
Figure Global Obesity Treating Neuromodulation System Sales 2014-2025 (Units)
Table Global Obesity Treating Neuromodulation System Market Size by Regions 2014-2019 (Units) & (Million US$)
Table Global Obesity Treating Neuromodulation System Sales by Regions 2014-2019 (Units)
Table Global Obesity Treating Neuromodulation System Sales Market Share by Regions 2014-2019
Figure Global Obesity Treating Neuromodulation System Sales Market Share by Regions 2014-2019
Figure 2018 Global Obesity Treating Neuromodulation System Sales Market Share by Regions
Table Global Obesity Treating Neuromodulation System Revenue by Regions 2014-2019 (Million US$)
Table Global Obesity Treating Neuromodulation System Revenue Market Share by Regions 2014-2019
Figure Global Obesity Treating Neuromodulation System Revenue Market Share by Regions 2014-2019
Figure 2018 Global Obesity Treating Neuromodulation System Revenue Market Share by Regions
Table Global Obesity Treating Neuromodulation System Sales by Manufacturers (2014-2019) (Units)
Table Global Obesity Treating Neuromodulation System Sales Share by Manufacturers (2014-2019)
Figure Global Obesity Treating Neuromodulation System Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Obesity Treating Neuromodulation System Revenue by Manufacturers (2014-2019) (Million USD)
Table Obesity Treating Neuromodulation System Revenue Share by Manufacturers (2014-2019)
Figure Obesity Treating Neuromodulation System Value Share by Manufacturers in 2018
Table Key Manufacturers Obesity Treating Neuromodulation System Price (2014-2019) (USD/Unit)
Table Obesity Treating Neuromodulation System Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Obesity Treating Neuromodulation System Product Type
Table Date of International Manufacturers Enter into Obesity Treating Neuromodulation System Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Obesity Treating Neuromodulation System Sales by Product (2014-2019) (Units)
Table Global Obesity Treating Neuromodulation System Sales Share by Product (2014-2019)
Figure Global Obesity Treating Neuromodulation System Sales Market Share by Product (2014-2019)
Figure Global Obesity Treating Neuromodulation System Sales Market Share by Product in 2018
Table Global Obesity Treating Neuromodulation System Revenue by Product (2014-2019) (Million US$)
Table Global Obesity Treating Neuromodulation System Revenue Share by Product (2014-2019)
Figure Global Obesity Treating Neuromodulation System Revenue Market Share by Product (2014-2019)
Figure Global Obesity Treating Neuromodulation System Revenue Market Share by Product in 2018
Table Obesity Treating Neuromodulation System Price by Product 2014-2019 (USD/Unit)
Table Global Obesity Treating Neuromodulation System Sales by End User (2014-2019) (Units)
Table Global Obesity Treating Neuromodulation System Sales Share by End User (2014-2019)
Figure Global Sales Obesity Treating Neuromodulation System Market Share by End User (2014-2019)
Figure Global Sales Obesity Treating Neuromodulation System Market Share by End User in 2018
Figure North America Obesity Treating Neuromodulation System Sales Growth Rate 2014-2019 (Units)
Figure North America Obesity Treating Neuromodulation System Revenue Growth Rate 2014-2019 (Million US$)
Table North America Obesity Treating Neuromodulation System Sales by Countries (2014-2019) (Units)
Table North America Obesity Treating Neuromodulation System Sales Market Share by Countries (2014-2019)
Figure 2018 North America Obesity Treating Neuromodulation System Sales Market Share by Countries
Table North America Obesity Treating Neuromodulation System Revenue by Countries (2014-2019) (Million US$)
Table North America Obesity Treating Neuromodulation System Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Obesity Treating Neuromodulation System Revenue Market Share by Countries
Figure United States Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure United States Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Units)
Figure Canada Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Canada Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Mexico Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Table North America Obesity Treating Neuromodulation System Sales by Product (2014-2019) (Units)
Table North America Obesity Treating Neuromodulation System Sales Market Share by Product (2014-2019)
Figure 2018 North America Obesity Treating Neuromodulation System Market Share by Product
Table North America Obesity Treating Neuromodulation System Sales by End User (2014-2019) (Units)
Table North America Obesity Treating Neuromodulation System Sales Market Share by End User (2014-2019)
Figure 2018 North America Obesity Treating Neuromodulation System Market Share by End User
Figure Europe Obesity Treating Neuromodulation System Sales Growth Rate 2014-2019 (Units)
Figure Europe Obesity Treating Neuromodulation System Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Obesity Treating Neuromodulation System Sales by Countries (2014-2019) (Units)
Table Europe Obesity Treating Neuromodulation System Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Obesity Treating Neuromodulation System Sales Market Share by Countries
Table Europe Obesity Treating Neuromodulation System Revenue by Countries (2014-2019) (Million US$)
Table Europe Obesity Treating Neuromodulation System Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Obesity Treating Neuromodulation System Revenue Market Share by Countries
Figure Germany Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Germany Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure France Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure France Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure UK Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Italy Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Russia Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Obesity Treating Neuromodulation System Sales by Product (2014-2019) (Units)
Table Europe Obesity Treating Neuromodulation System Sales Market Share by Product (2014-2019)
Figure 2018 Europe Obesity Treating Neuromodulation System Market Share by Product
Table Europe Obesity Treating Neuromodulation System Sales by End User (2014-2019) (Units)
Table Europe Obesity Treating Neuromodulation System Sales Market Share by End User (2014-2019)
Figure 2018 Europe Obesity Treating Neuromodulation System Market Share by End User
Figure Asia Pacific Obesity Treating Neuromodulation System Sales Growth Rate 2014-2019 (Units)
Figure Asia Pacific Obesity Treating Neuromodulation System Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Obesity Treating Neuromodulation System Sales by Countries (2014-2019) (Units)
Table Asia Pacific Obesity Treating Neuromodulation System Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Obesity Treating Neuromodulation System Sales Market Share by Countries
Table Asia Pacific Obesity Treating Neuromodulation System Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Obesity Treating Neuromodulation System Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Obesity Treating Neuromodulation System Revenue Market Share by Countries
Figure China Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure China Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Japan Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Korea Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure India Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure India Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Australia Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Indonesia Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Malaysia Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Philippines Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Thailand Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Vietnam Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Singapore Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Obesity Treating Neuromodulation System Sales by Product (2014-2019) (Units)
Table Asia Pacific Obesity Treating Neuromodulation System Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Obesity Treating Neuromodulation System Market Share by Product
Table Asia Pacific Obesity Treating Neuromodulation System Sales by End User (2014-2019) (Units)
Table Asia Pacific Obesity Treating Neuromodulation System Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Obesity Treating Neuromodulation System Market Share by End User
Figure Central & South America Obesity Treating Neuromodulation System Sales Growth Rate 2014-2019 (Units)
Figure Central & South America Obesity Treating Neuromodulation System Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Obesity Treating Neuromodulation System Sales by Countries (2014-2019) (Units)
Table Central & South America Obesity Treating Neuromodulation System Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Obesity Treating Neuromodulation System Sales Market Share by Countries
Table Central & South America Obesity Treating Neuromodulation System Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Obesity Treating Neuromodulation System Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Obesity Treating Neuromodulation System Revenue Market Share by Countries
Figure Brazil Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Brazil Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Argentina Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Obesity Treating Neuromodulation System Sales by Product (2014-2019) (Units)
Table Central & South America Obesity Treating Neuromodulation System Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Obesity Treating Neuromodulation System Market Share by Product
Table Central & South America Obesity Treating Neuromodulation System Sales by End User (2014-2019) (Units)
Table Central & South America Obesity Treating Neuromodulation System Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Obesity Treating Neuromodulation System Market Share by End User
Figure Middle East and Africa Obesity Treating Neuromodulation System Sales Growth Rate 2014-2019 (Units)
Figure Middle East and Africa Obesity Treating Neuromodulation System Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Obesity Treating Neuromodulation System Sales by Countries (2014-2019) (Units)
Table Middle East and Africa Obesity Treating Neuromodulation System Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Obesity Treating Neuromodulation System Sales Market Share by Countries
Table Middle East and Africa Obesity Treating Neuromodulation System Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Obesity Treating Neuromodulation System Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Obesity Treating Neuromodulation System Revenue Market Share by Countries
Figure GCC Countries Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure GCC Countries Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Turkey Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure Egypt Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Obesity Treating Neuromodulation System Sales Growth Rate (2014-2019) (Units)
Figure South Africa Obesity Treating Neuromodulation System Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Obesity Treating Neuromodulation System Sales by Product (2014-2019) (Units)
Table Middle East and Africa Obesity Treating Neuromodulation System Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Obesity Treating Neuromodulation System Market Share by Product
Table Middle East and Africa Obesity Treating Neuromodulation System Sales by End User (2014-2019) (Units)
Table Middle East and Africa Obesity Treating Neuromodulation System Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Obesity Treating Neuromodulation System Market Share by End User
Table Medtronic Company Details
Table Medtronic Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Medtronic Recent Development
Table Cyberonics Company Details
Table Cyberonics Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cyberonics Recent Development
Table St. Jude Medical Company Details
Table St. Jude Medical Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table St. Jude Medical Recent Development
Table BioControl Medical Company Details
Table BioControl Medical Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BioControl Medical Recent Development
Table Leptos Medical Company Details
Table Leptos Medical Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Leptos Medical Recent Development
Table EnteroMedics Company Details
Table EnteroMedics Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table EnteroMedics Recent Development
Table Nevro Company Details
Table Nevro Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nevro Recent Development
Table Nuvectra Company Details
Table Nuvectra Obesity Treating Neuromodulation System Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nuvectra Recent Development
Table Global Obesity Treating Neuromodulation System Sales Forecast by Regions 2019-2025 (Units)
Table Global Obesity Treating Neuromodulation System Sales Market Share Forecast by Regions 2019-2025
Table Global Obesity Treating Neuromodulation System Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Obesity Treating Neuromodulation System Revenue Market Share Forecast by Regions 2019-2025
Table Global Obesity Treating Neuromodulation System Sales Forecast by Product 2019-2025 (Units)
Table Global Obesity Treating Neuromodulation System Sales Market Share Forecast by Product 2019-2025
Table Global Obesity Treating Neuromodulation System Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Obesity Treating Neuromodulation System Revenue Market Share Forecast by Product 2019-2025
Table Global Obesity Treating Neuromodulation System Sales Forecast by End User 2019-2025 (Units)
Table Global Obesity Treating Neuromodulation System Sales Market Share Forecast by End User 2019-2025
Figure North America Obesity Treating Neuromodulation System Sales Growth Rate Forecast (2019-2025) (Units)
Figure North America Obesity Treating Neuromodulation System Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Obesity Treating Neuromodulation System Sales Growth Rate Forecast (2019-2025) (Units)
Figure Europe Obesity Treating Neuromodulation System Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Obesity Treating Neuromodulation System Sales Growth Rate Forecast (2019-2025) (Units)
Figure Asia Pacific Obesity Treating Neuromodulation System Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Obesity Treating Neuromodulation System Sales Growth Rate Forecast (2019-2025) (Units)
Figure Central & South America Obesity Treating Neuromodulation System Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Obesity Treating Neuromodulation System Sales Growth Rate Forecast (2019-2025) (Units)
Figure Middle East and Africa Obesity Treating Neuromodulation System Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Obesity Treating Neuromodulation System Value Chain
Table Obesity Treating Neuromodulation System Customers List
Table Obesity Treating Neuromodulation System Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
ニューロモデュレーションの世界市場：市場規模・現状・予測 Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. The key drivers for the growth of neuromodulation market include rise in geriatric population, their vulnerability for neurological disorders, increase in incid…- ニューロモデュレーションの世界市場：市場規模・現状・予測 Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. The key drivers for the growth of neuromodulation market include rise in geriatric population, their vulnerability for neurological disorders, increase in incid…
- 世界の迷走神経刺激（VNS）デバイス市場：動向・競争分析 Vagus nerve stimulation (VNS) may prevent or lessen seizures by sending regular, mild pulses of electrical energy to the brain via the vagus nerve. The therapy consists of a device that is implanted under the skin in the left chest area.The Vagus Nerve Stimulation (VNS) Devices market was valued at …
- 世界の迷走神経刺激（VNS）デバイス市場：動向・競争分析 Vagus nerve stimulation (VNS) may prevent or lessen seizures by sending regular, mild pulses of electrical energy to the brain via the vagus nerve. The therapy consists of a device that is implanted under the skin in the left chest area.The Vagus Nerve Stimulation (VNS) Devices market was valued at …
- 世界の金属処理液市場：専門的調査 Metalworking fluids (MWFs) are used to reduce heat and friction and to remove metal particles in industrial machining and grinding operations. There are numerous formulations, ranging from straight oils (such as petroleum oils) to water-based fluids, which include soluble oils and semisynthetic/synt…